Swing Traders' Favorite: Stanley Druckenmiller's 34 New Positions in Q3 2024

The latest 13F filings are out, highlighting the major moves made by top investors in Q3 2024. These reports provide valuable insights into the strategies of the “smart money.” As always, swing traders’ favorite, Stanley Druckenmiller's DUQUESNE FAMILY OFFICE LLC, has unveiled its new positions.

Here are the details of the new positions, including ticker, estimated average price, and current market value. PS: Add these to your charting platform's watchlist panel, and you might be able to reverse engineer his selection criteria.

$Truist Financial Corp(TFC)$ $40.96 $9.99M

$Western Digital(WDC)$ $69.12 $4.88M

$Seagate Technology PLC(STX)$ CALL - $28.81M

$First Horizon National(FHN)$ $15.67 $9.62M

$M&T Bank(MTB)$ $161.32 $10.01M

$U.S. Steel(X)$ $37.89 $23.43M

$Teva Pharmaceutical(TEVA)$ $17.35 $25.73M

$TC Energy(TRP)$ $42.39 $5.49M

$Chubb(CB)$ $271.70 $10.04M

$Taiwan Semiconductor Manufacturing(TSM)$ $170.11 $9.96M

$First Citizens BancShares(FCNCA)$ $1851.73 $9.54M

$Ameris(ABCB)$ $56.09 $9.61M

$XPO Logistics(XPO)$ $110.41 $5.00M

$SPDR S&P Regional Banking ETF(KRE)$ $53.18 $116.22M

$Huntington Bancshares(HBAN)$ $13.89 $9.87M

$CRH PLC(CRH)$ $82.34 $15.07M

$Broadcom(AVGO)$ $159.36 $41.40M

$Ultragenyx Pharmaceutical(RARE)$ $48.60 $4.75M

$Citizens(CFG)$ $39.08 $9.80M

$Ascendis Pharma A/S(ASND)$ $134.26 $39.57M

$Verona Pharma plc(VRNA)$ $22.22 $19.74M

$nVent Electric plc(NVT)$ $71.12 $31.69M

$Vaxcyte, Inc.(PCVX)$ $86.32 $4.91M

$ARS PHARMACEUTICALS INC(SPRY)$ $11.13 $7.79M

$NEWAMSTERDAM PHARMA CO NV(NAMS)$ $17.70 $4.77M

$Core & Main, Inc.(CNM)$ $48.35 $21.10M

$TPG, Inc.(TPG)$ PUT - $12.52M

$ARM Holdings Ltd(ARM)$ $144.28 $3.09M

$U.S. Bancorp(USB)$ $42.82 $9.94M

$KeyCorp(KEY)$ $15.38 $9.78M

$Starbucks(SBUX)$ $84.54 $5.10M

$Citigroup(C)$ $61.65 $20.50M

$Autodesk(ADSK)$ $246.62 $10.03M

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • TigerPicks
    ·2024-11-27

    Are the Stanley Druckenmiller's 34 New Positions in Q3 2024 Your Favorite target?

    Reply
    Report